Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: DewDiligence_on_SI	12/8/2010 9:57:45 PM
	of 3027

MNTA ‘ReadMeFirst’ updated: latest financing transaction; musings on use of the new money; updated share count for valuation purposes; generic Lovenox has >50% script share; MNTA sues Teva for patent infringement; musings on the rationale for MNTA’s lawsuit; musings on the M118 phase-2b program; what is Angiomax?; Copaxone FUD from Sanford Bernstein; transcript of Nov 2010 FDA hearing on FoB’s; new patent applications; new version of “What’s New in the Anticoagulant Arena?” siliconinvestor.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next